Substance · official US FDA label
Loperamide (loperamide)
36 medicines listed on Vimpia contain it, alone or combined. Below, the official US FDA label for loperamide, unchanged.
Want to buy it?
Trouver shows the pharmacies near you that have it right now, and their prices. The reservation pages are in French.
This is a US label.
The official US FDA label for loperamide (published as LOPERAMIDE HYDROCHLORIDE), effective September 9, 2026, describes products sold in the United States. The medicine sold in DR Congo may differ in strength, form or approved uses: ask a pharmacist or a doctor.
Official US FDA label for loperamide
Data provided by the U.S. Food and Drug Administration (openFDA), unchanged. The full label on DailyMed.
Uses
Use controls symptoms of diarrhea, including Travelers' Diarrhea
Dosage
US dosage, for products sold in the United States. For a medicine bought in DR Congo, follow its box, its leaflet or your pharmacist.
Directions drink plenty of clear fluids to help prevent dehydration caused by diarrhea. not for use in children under 12 years of age adults and children 12 years and over: 2 softgels after the first loose stool; 1 softgel after each subsequent loose stool; but no more than 4 softgels in 24 hours
Warnings and precautions
Warnings Allergy alert: Do not use if you have ever had a rash or other allergic reaction to loperamide hydrochloride Heart alert: Taking more than directed can cause serious heart problems or death
Medicines that contain it
Names as they are sold. A medicine without an English page links to its French page.
- Diarasol 2 mg, comprimé
- DIARETYL 2 mg, gélule
- DIASTROLIB 2 mg, lyophilisat oral
- Dyarex 2 mg, gélule
- IMODIUM 2 mg, gélule
- IMODIUMCAPS 2 mg, gélule
- IMODIUMLINGUAL 2 mg, lyophilisat oral
- IMODIUMLINGUAL 2 mg, lyophilisat oral
- IMODIUMLIQUICAPS 2 mg, capsule molle
- Loperamide 2 mg, Comprimé
- LOPERAMIDE ALMUS 2 mg, gélule
- LOPERAMIDE ARROW CONSEIL 2 mg, comprimé orodispersible
- LOPERAMIDE ARROW CONSEIL 2 mg, gélule
- LOPERAMIDE ARROW LAB 2 mg, gélule
- LOPERAMIDE BGR CONSEIL 2 mg, comprimé orodispersible
- LOPERAMIDE BIOGARAN 2 mg, gélule
- LOPERAMIDE BIOGARAN CONSEIL 2 mg, gélule
- LOPERAMIDE EG 2 mg, gélule
- LOPERAMIDE EG CONSEIL 2 mg, comprimé orodispersible
- LOPERAMIDE EVOLUGEN 2 mg, gélule
- LOPERAMIDE LYOC 2 mg, lyophilisat oral
- LOPERAMIDE SANDOZ 2 mg, gélule
- LOPERAMIDE SANDOZ CONSEIL 2 mg, gélule
- LOPERAMIDE TEVA 2 mg, comprimé pelliculé
- LOPERAMIDE TEVA CONSEIL 2 mg, gélule
- LOPERAMIDE VIATRIS 2 mg, gélule
- LOPERAMIDE VIATRIS CONSEIL 2 mg, gélule
- LOPERAMIDE VIATRIS CONSEIL 2 mg, lyophilisat oral
- LOPERAMIDE ZENTIVA 2 mg, gélule
- LOPERAMIDE ZENTIVA CONSEIL 2 mg, gélule
- LOPERAMIDE ZYDUS 2 mg, gélule
- LOPERAMIDE ZYDUS FRANCE 2 mg, gélule
- LOPRAVIE 2 mg, comprimé non enrobé
- Lopéramide 2 mg, Comprimé ; gélule
- Lotrimide 2mg, capsule
- Milicine 2 mg, comprimé
Sources
- ●Labels: U.S. Food and Drug Administration, openFDA (public domain). Data provided by the U.S. Food and Drug Administration (openFDA), unchanged. DailyMed.
- ●English names of substances: RxNorm, U.S. National Library of Medicine.
- ●Marketing authorizations: register of the ACOREP, DR Congo.
- ●Essential medicines: national list of essential medicines of DR Congo (LNME).
- ●Composition: public medicines database of France (BDPM), ANSM, open licence.
Public information, for reference only: it does not replace the advice of a pharmacist or a doctor. Vimpia writes nothing about how to use a medicine and translates nothing: the label is the US FDA's, unchanged; names, composition and authorizations come from the official sources above.